Gene Symbol | Gene ID | Gene Info |
---|---|---|
VSX1
|
ENSG00000100987.10 | visual system homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr20_25071710_25071861 | VSX1 | 8789 | 0.209651 | -0.47 | 2.0e-01 | Click! |
chr20_25064794_25064945 | VSX1 | 1873 | 0.363721 | -0.45 | 2.3e-01 | Click! |
chr20_25064515_25064666 | VSX1 | 1594 | 0.408889 | -0.23 | 5.5e-01 | Click! |
chr20_25064050_25064221 | VSX1 | 1139 | 0.524864 | 0.22 | 5.6e-01 | Click! |
chr20_25064259_25064410 | VSX1 | 1338 | 0.466158 | 0.05 | 9.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_12849556_12849989 | 0.42 |
RP11-47J17.3 |
|
4558 |
0.23 |
chr16_62022994_62023145 | 0.38 |
CDH8 |
cadherin 8, type 2 |
32437 |
0.22 |
chr3_112356169_112356393 | 0.37 |
CCDC80 |
coiled-coil domain containing 80 |
663 |
0.77 |
chr15_96881050_96881298 | 0.31 |
ENSG00000222651 |
. |
4684 |
0.17 |
chr2_217235630_217236249 | 0.31 |
MARCH4 |
membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase |
811 |
0.59 |
chrX_34671991_34672311 | 0.30 |
TMEM47 |
transmembrane protein 47 |
3254 |
0.41 |
chr10_25008347_25008498 | 0.30 |
ARHGAP21 |
Rho GTPase activating protein 21 |
2373 |
0.41 |
chr17_66700653_66700804 | 0.28 |
ENSG00000263690 |
. |
61972 |
0.13 |
chr6_74226468_74226678 | 0.28 |
EEF1A1 |
eukaryotic translation elongation factor 1 alpha 1 |
4168 |
0.13 |
chr15_96878465_96878729 | 0.28 |
ENSG00000222651 |
. |
2107 |
0.24 |
chr1_236046389_236046555 | 0.28 |
LYST |
lysosomal trafficking regulator |
400 |
0.83 |
chr1_196577911_196578299 | 0.27 |
KCNT2 |
potassium channel, subfamily T, member 2 |
250 |
0.94 |
chr6_111984874_111985025 | 0.27 |
ENSG00000239015 |
. |
17319 |
0.19 |
chr2_189158529_189158680 | 0.25 |
GULP1 |
GULP, engulfment adaptor PTB domain containing 1 |
59 |
0.98 |
chr3_173266211_173266362 | 0.25 |
NLGN1 |
neuroligin 1 |
36059 |
0.24 |
chr6_127780261_127780437 | 0.25 |
KIAA0408 |
KIAA0408 |
161 |
0.97 |
chr1_164532131_164532342 | 0.25 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
194 |
0.97 |
chr1_245461989_245462162 | 0.25 |
RP11-62I21.1 |
|
64272 |
0.12 |
chr11_31831142_31831293 | 0.24 |
PAX6 |
paired box 6 |
636 |
0.72 |
chr11_106239153_106239583 | 0.24 |
RP11-680E19.1 |
|
104326 |
0.08 |
chr1_99126586_99127126 | 0.24 |
SNX7 |
sorting nexin 7 |
380 |
0.93 |
chr10_119564055_119564206 | 0.24 |
RP11-354M20.3 |
|
212868 |
0.02 |
chr14_52534801_52535890 | 0.24 |
NID2 |
nidogen 2 (osteonidogen) |
367 |
0.89 |
chr12_18622010_18622161 | 0.24 |
PIK3C2G |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
187107 |
0.03 |
chr4_71997150_71997347 | 0.24 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
55755 |
0.16 |
chr9_100069620_100070257 | 0.24 |
CCDC180 |
coiled-coil domain containing 180 |
3 |
0.98 |
chr3_79067433_79067887 | 0.24 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
34 |
0.99 |
chr15_101261674_101262051 | 0.24 |
ENSG00000212306 |
. |
83294 |
0.08 |
chr8_121137253_121137925 | 0.24 |
COL14A1 |
collagen, type XIV, alpha 1 |
237 |
0.96 |
chr20_56749874_56750278 | 0.23 |
C20orf85 |
chromosome 20 open reading frame 85 |
24116 |
0.19 |
chr8_37350646_37351319 | 0.23 |
RP11-150O12.6 |
|
23557 |
0.24 |
chr5_15501266_15501663 | 0.23 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
83 |
0.99 |
chr6_85256272_85256423 | 0.23 |
RP11-132M7.3 |
|
142796 |
0.05 |
chr4_123776122_123776354 | 0.22 |
ENSG00000253069 |
. |
28069 |
0.14 |
chr5_110429004_110429186 | 0.22 |
WDR36 |
WD repeat domain 36 |
1076 |
0.41 |
chr11_124733143_124733554 | 0.22 |
ROBO3 |
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
1934 |
0.2 |
chr19_9473504_9474272 | 0.22 |
ZNF177 |
zinc finger protein 177 |
181 |
0.93 |
chr8_89336204_89336358 | 0.22 |
RP11-586K2.1 |
|
2784 |
0.3 |
chr17_13503089_13503240 | 0.22 |
HS3ST3A1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
2080 |
0.42 |
chr1_76757094_76757245 | 0.22 |
ST6GALNAC3 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 |
216765 |
0.02 |
chr19_2185882_2186045 | 0.21 |
DOT1L |
DOT1-like histone H3K79 methyltransferase |
21779 |
0.09 |
chr1_214723042_214723197 | 0.21 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
1447 |
0.54 |
chr18_65188257_65188408 | 0.21 |
DSEL |
dermatan sulfate epimerase-like |
4115 |
0.29 |
chr5_32803819_32803970 | 0.21 |
AC026703.1 |
|
14949 |
0.22 |
chr14_24838154_24838623 | 0.21 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
15 |
0.95 |
chr16_86603613_86603777 | 0.21 |
RP11-463O9.5 |
|
2328 |
0.23 |
chr1_162603392_162603656 | 0.21 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
1264 |
0.48 |
chr5_16916952_16917142 | 0.21 |
MYO10 |
myosin X |
411 |
0.87 |
chr12_19358284_19358561 | 0.21 |
PLEKHA5 |
pleckstrin homology domain containing, family A member 5 |
163 |
0.96 |
chr5_16713576_16713796 | 0.21 |
MYO10 |
myosin X |
24810 |
0.21 |
chr11_8831505_8831934 | 0.20 |
ST5 |
suppression of tumorigenicity 5 |
477 |
0.76 |
chr8_42063953_42065062 | 0.20 |
PLAT |
plasminogen activator, tissue |
576 |
0.71 |
chr18_52721804_52722049 | 0.20 |
ENSG00000264804 |
. |
53297 |
0.15 |
chr13_24146066_24146217 | 0.20 |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
1338 |
0.59 |
chr12_65997242_65997414 | 0.20 |
HMGA2 |
high mobility group AT-hook 2 |
220583 |
0.02 |
chr21_32591500_32591929 | 0.20 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
57369 |
0.16 |
chr2_40098959_40099110 | 0.20 |
SLC8A1-AS1 |
SLC8A1 antisense RNA 1 |
47799 |
0.18 |
chr17_45331851_45332126 | 0.20 |
ITGB3 |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
725 |
0.57 |
chr6_53928552_53928746 | 0.20 |
MLIP-AS1 |
MLIP antisense RNA 1 |
15875 |
0.2 |
chr1_118238331_118238482 | 0.20 |
ENSG00000212266 |
. |
7042 |
0.28 |
chr2_157659750_157659995 | 0.20 |
ENSG00000263848 |
. |
211897 |
0.02 |
chr2_74606600_74607395 | 0.20 |
DCTN1 |
dynactin 1 |
413 |
0.73 |
chr2_100297290_100297441 | 0.20 |
AFF3 |
AF4/FMR2 family, member 3 |
102533 |
0.08 |
chr13_95003800_95004010 | 0.20 |
ENSG00000212057 |
. |
113739 |
0.06 |
chr13_96295623_96295774 | 0.20 |
DZIP1 |
DAZ interacting zinc finger protein 1 |
181 |
0.96 |
chr13_24044512_24044663 | 0.19 |
SACS |
spastic ataxia of Charlevoix-Saguenay (sacsin) |
36746 |
0.21 |
chr5_111090218_111090459 | 0.19 |
NREP |
neuronal regeneration related protein |
1610 |
0.42 |
chr2_144692978_144693129 | 0.19 |
AC016910.1 |
|
1587 |
0.49 |
chr13_33803610_33803839 | 0.19 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
23581 |
0.2 |
chr18_60278197_60278407 | 0.19 |
ENSG00000243549 |
. |
39532 |
0.17 |
chr15_96886136_96886425 | 0.19 |
ENSG00000222651 |
. |
9790 |
0.16 |
chr13_111768316_111768682 | 0.19 |
ARHGEF7-AS2 |
ARHGEF7 antisense RNA 2 |
474 |
0.54 |
chr4_81198150_81198317 | 0.19 |
FGF5 |
fibroblast growth factor 5 |
10440 |
0.25 |
chr12_44131589_44131740 | 0.19 |
RP11-210N13.1 |
|
968 |
0.56 |
chr1_182932139_182932350 | 0.19 |
ENSG00000264768 |
. |
3534 |
0.19 |
chr1_107682797_107683388 | 0.19 |
NTNG1 |
netrin G1 |
350 |
0.93 |
chr6_52440366_52440800 | 0.19 |
TRAM2 |
translocation associated membrane protein 2 |
1130 |
0.59 |
chr11_57530814_57530965 | 0.19 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
436 |
0.77 |
chr17_47547430_47548013 | 0.19 |
NGFR |
nerve growth factor receptor |
24934 |
0.13 |
chr3_106060605_106060757 | 0.18 |
ENSG00000200610 |
. |
174063 |
0.04 |
chr11_111849006_111849202 | 0.18 |
DIXDC1 |
DIX domain containing 1 |
1071 |
0.39 |
chr12_22059820_22060034 | 0.18 |
ABCC9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
3985 |
0.3 |
chr7_93552303_93552503 | 0.18 |
GNG11 |
guanine nucleotide binding protein (G protein), gamma 11 |
1392 |
0.38 |
chr9_98188423_98189086 | 0.18 |
PTCH1 |
patched 1 |
54013 |
0.12 |
chr4_187025490_187026623 | 0.18 |
FAM149A |
family with sequence similarity 149, member A |
175 |
0.94 |
chr15_39876247_39876621 | 0.18 |
THBS1 |
thrombospondin 1 |
3140 |
0.25 |
chr10_18629419_18629841 | 0.18 |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
36 |
0.99 |
chr4_52903402_52903553 | 0.18 |
SGCB |
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
948 |
0.59 |
chr15_57124208_57124359 | 0.18 |
ZNF280D |
zinc finger protein 280D |
86486 |
0.09 |
chr12_105711891_105712042 | 0.18 |
RP11-474B16.1 |
|
8829 |
0.18 |
chr6_155475558_155475911 | 0.18 |
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
5479 |
0.3 |
chr16_56811456_56811607 | 0.18 |
NUP93 |
nucleoporin 93kDa |
4039 |
0.18 |
chr6_84743193_84743395 | 0.18 |
MRAP2 |
melanocortin 2 receptor accessory protein 2 |
181 |
0.97 |
chr3_114343374_114343541 | 0.18 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
335 |
0.94 |
chr2_101435204_101435829 | 0.18 |
NPAS2 |
neuronal PAS domain protein 2 |
1098 |
0.54 |
chr5_88129391_88129549 | 0.18 |
MEF2C |
myocyte enhancer factor 2C |
6495 |
0.28 |
chr5_148786412_148786563 | 0.18 |
ENSG00000208035 |
. |
21994 |
0.11 |
chr3_63037895_63038046 | 0.18 |
CADPS |
Ca++-dependent secretion activator |
176916 |
0.03 |
chr4_170188382_170188561 | 0.18 |
SH3RF1 |
SH3 domain containing ring finger 1 |
2637 |
0.38 |
chr7_130606573_130606804 | 0.18 |
ENSG00000226380 |
. |
44390 |
0.16 |
chr14_62230360_62230511 | 0.18 |
SNAPC1 |
small nuclear RNA activating complex, polypeptide 1, 43kDa |
1360 |
0.55 |
chr9_104248314_104249564 | 0.17 |
TMEM246 |
transmembrane protein 246 |
460 |
0.79 |
chr6_148829582_148830289 | 0.17 |
ENSG00000223322 |
. |
15441 |
0.29 |
chr4_78620774_78621041 | 0.17 |
ENSG00000221711 |
. |
3050 |
0.34 |
chr5_121648324_121648736 | 0.17 |
SNCAIP |
synuclein, alpha interacting protein |
268 |
0.87 |
chr2_227834271_227834422 | 0.17 |
ENSG00000212391 |
. |
508 |
0.85 |
chr9_4927714_4927865 | 0.17 |
ENSG00000238362 |
. |
40308 |
0.13 |
chr2_134024891_134025042 | 0.17 |
AC010890.1 |
|
1152 |
0.61 |
chr15_60685776_60685927 | 0.17 |
ANXA2 |
annexin A2 |
2355 |
0.39 |
chr20_42544114_42544359 | 0.17 |
TOX2 |
TOX high mobility group box family member 2 |
554 |
0.83 |
chrX_135287572_135287723 | 0.17 |
FHL1 |
four and a half LIM domains 1 |
767 |
0.7 |
chr9_21688149_21688723 | 0.17 |
ENSG00000244230 |
. |
10877 |
0.24 |
chr11_126869922_126870139 | 0.17 |
KIRREL3 |
kin of IRRE like 3 (Drosophila) |
386 |
0.81 |
chr6_100729238_100729940 | 0.17 |
RP1-121G13.2 |
|
145405 |
0.05 |
chr13_102105579_102105898 | 0.17 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
720 |
0.77 |
chr12_106812256_106812407 | 0.17 |
POLR3B |
polymerase (RNA) III (DNA directed) polypeptide B |
36581 |
0.19 |
chr1_70406023_70406174 | 0.17 |
ENSG00000240692 |
. |
60823 |
0.14 |
chr4_81193524_81193675 | 0.17 |
FGF5 |
fibroblast growth factor 5 |
5806 |
0.27 |
chr11_10962454_10962605 | 0.17 |
ZBED5-AS1 |
ZBED5 antisense RNA 1 |
75721 |
0.09 |
chr13_73081776_73081993 | 0.17 |
ENSG00000251715 |
. |
47145 |
0.15 |
chr17_1914930_1915193 | 0.17 |
AC099684.1 |
|
5949 |
0.1 |
chr18_12309689_12309931 | 0.17 |
TUBB6 |
tubulin, beta 6 class V |
1156 |
0.46 |
chr7_97361017_97361340 | 0.17 |
TAC1 |
tachykinin, precursor 1 |
42 |
0.99 |
chr15_25936715_25936881 | 0.17 |
ATP10A |
ATPase, class V, type 10A |
3174 |
0.29 |
chr9_94753972_94754242 | 0.17 |
ROR2 |
receptor tyrosine kinase-like orphan receptor 2 |
41663 |
0.19 |
chr4_87517094_87517245 | 0.17 |
PTPN13 |
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) |
323 |
0.88 |
chr3_61546098_61546562 | 0.17 |
PTPRG |
protein tyrosine phosphatase, receptor type, G |
1255 |
0.64 |
chr8_22023419_22024083 | 0.17 |
BMP1 |
bone morphogenetic protein 1 |
951 |
0.4 |
chr2_201651988_201652246 | 0.17 |
ENSG00000201737 |
. |
11810 |
0.12 |
chr17_1994078_1994475 | 0.17 |
RP11-667K14.5 |
|
1301 |
0.3 |
chr2_181388977_181389207 | 0.17 |
ENSG00000264976 |
. |
92841 |
0.1 |
chr7_95107815_95108198 | 0.17 |
ASB4 |
ankyrin repeat and SOCS box containing 4 |
7207 |
0.2 |
chr15_86167470_86167715 | 0.17 |
RP11-815J21.3 |
|
3328 |
0.19 |
chr9_18476160_18476529 | 0.17 |
ADAMTSL1 |
ADAMTS-like 1 |
2113 |
0.45 |
chr3_16024121_16024347 | 0.17 |
ENSG00000207815 |
. |
108956 |
0.06 |
chr5_91941448_91941599 | 0.17 |
ENSG00000221810 |
. |
111697 |
0.07 |
chr20_18720686_18720868 | 0.17 |
RP11-379J5.5 |
|
41424 |
0.15 |
chr5_88238815_88238969 | 0.17 |
MEF2C-AS1 |
MEF2C antisense RNA 1 |
12 |
0.99 |
chr7_70060715_70061143 | 0.16 |
AUTS2 |
autism susceptibility candidate 2 |
133196 |
0.06 |
chr3_98619314_98619465 | 0.16 |
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
626 |
0.66 |
chr5_112033189_112033368 | 0.16 |
APC |
adenomatous polyposis coli |
9917 |
0.26 |
chr4_114898942_114899097 | 0.16 |
ARSJ |
arylsulfatase family, member J |
1133 |
0.61 |
chr4_187646786_187647042 | 0.16 |
FAT1 |
FAT atypical cadherin 1 |
962 |
0.7 |
chr15_33154166_33154394 | 0.16 |
FMN1 |
formin 1 |
26175 |
0.19 |
chr11_122597673_122598179 | 0.16 |
ENSG00000239079 |
. |
907 |
0.67 |
chr1_93389452_93389603 | 0.16 |
FAM69A |
family with sequence similarity 69, member A |
37530 |
0.1 |
chr3_54277662_54277813 | 0.16 |
CACNA2D3 |
calcium channel, voltage-dependent, alpha 2/delta subunit 3 |
65914 |
0.14 |
chr10_63813819_63813970 | 0.16 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
4924 |
0.3 |
chr9_137380907_137381058 | 0.16 |
RXRA |
retinoid X receptor, alpha |
82554 |
0.09 |
chr8_97744511_97744662 | 0.16 |
CPQ |
carboxypeptidase Q |
28616 |
0.25 |
chr1_45083000_45083241 | 0.16 |
RNF220 |
ring finger protein 220 |
8878 |
0.17 |
chr5_31193803_31195028 | 0.16 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr7_87229218_87230455 | 0.16 |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
336 |
0.9 |
chr9_13278507_13279169 | 0.16 |
RP11-272P10.2 |
|
348 |
0.67 |
chr10_105211471_105211777 | 0.16 |
CALHM2 |
calcium homeostasis modulator 2 |
451 |
0.57 |
chr8_41165312_41165463 | 0.16 |
SFRP1 |
secreted frizzled-related protein 1 |
878 |
0.57 |
chr20_25290950_25291163 | 0.16 |
ABHD12 |
abhydrolase domain containing 12 |
922 |
0.6 |
chr11_58874492_58875123 | 0.16 |
FAM111B |
family with sequence similarity 111, member B |
97 |
0.97 |
chr20_62600161_62600928 | 0.16 |
ZNF512B |
zinc finger protein 512B |
674 |
0.45 |
chr8_27405445_27405654 | 0.16 |
CLU |
clusterin |
51983 |
0.11 |
chr18_10660519_10660670 | 0.16 |
RP11-856M7.1 |
|
1336 |
0.48 |
chr11_19585849_19586032 | 0.16 |
ENSG00000265210 |
. |
10917 |
0.19 |
chr5_71406834_71406985 | 0.16 |
MAP1B |
microtubule-associated protein 1B |
3596 |
0.33 |
chr8_60190630_60190781 | 0.16 |
ENSG00000206853 |
. |
140644 |
0.05 |
chr4_114680711_114680982 | 0.16 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
1378 |
0.6 |
chr9_21988401_21988572 | 0.16 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
5924 |
0.15 |
chr16_86353722_86353873 | 0.15 |
ENSG00000199949 |
. |
44668 |
0.19 |
chr6_131290698_131290904 | 0.15 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
822 |
0.76 |
chr12_115135696_115136278 | 0.15 |
TBX3 |
T-box 3 |
14018 |
0.21 |
chr22_28010083_28010492 | 0.15 |
RP11-375H17.1 |
|
102181 |
0.08 |
chr6_39787271_39787422 | 0.15 |
DAAM2 |
dishevelled associated activator of morphogenesis 2 |
26552 |
0.21 |
chr5_76979205_76979356 | 0.15 |
TBCA |
tubulin folding cofactor A |
31862 |
0.19 |
chr21_17652021_17652264 | 0.15 |
ENSG00000201025 |
. |
4947 |
0.35 |
chr18_53089837_53090372 | 0.15 |
TCF4 |
transcription factor 4 |
361 |
0.89 |
chr12_5294701_5295025 | 0.15 |
KCNA5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
141778 |
0.05 |
chr7_15724696_15724847 | 0.15 |
MEOX2 |
mesenchyme homeobox 2 |
1666 |
0.46 |
chr12_13500259_13500486 | 0.15 |
C12orf36 |
chromosome 12 open reading frame 36 |
28992 |
0.21 |
chr8_105235287_105235872 | 0.15 |
RIMS2 |
regulating synaptic membrane exocytosis 2 |
13 |
0.99 |
chr8_93660376_93660527 | 0.15 |
ENSG00000221172 |
. |
12888 |
0.29 |
chr4_18595074_18595257 | 0.15 |
LCORL |
ligand dependent nuclear receptor corepressor-like |
571666 |
0.0 |
chr6_5498160_5498518 | 0.15 |
RP1-232P20.1 |
|
40031 |
0.2 |
chr17_38707848_38708142 | 0.15 |
CCR7 |
chemokine (C-C motif) receptor 7 |
9270 |
0.17 |
chr10_110672045_110672364 | 0.15 |
ENSG00000222436 |
. |
28864 |
0.27 |
chr3_178787181_178787457 | 0.15 |
ZMAT3 |
zinc finger, matrin-type 3 |
2035 |
0.36 |
chr1_226285926_226286101 | 0.15 |
H3F3A |
H3 histone, family 3A |
34335 |
0.13 |
chr2_213401933_213402296 | 0.15 |
ERBB4 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
1139 |
0.66 |
chr7_130479581_130479757 | 0.15 |
KLF14 |
Kruppel-like factor 14 |
60781 |
0.12 |
chr6_160151501_160151652 | 0.15 |
WTAP |
Wilms tumor 1 associated protein |
2956 |
0.17 |
chr2_53795780_53795969 | 0.15 |
ENSG00000207456 |
. |
1743 |
0.47 |
chr6_3750219_3750380 | 0.15 |
RP11-420L9.5 |
|
1046 |
0.5 |
chr2_188354408_188354559 | 0.15 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
23885 |
0.21 |
chr7_100777700_100777901 | 0.15 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
7421 |
0.1 |
chr1_227413559_227414076 | 0.15 |
RP11-1B20.1 |
|
47783 |
0.17 |
chr12_66220556_66220804 | 0.15 |
HMGA2 |
high mobility group AT-hook 2 |
1777 |
0.39 |
chr17_9176686_9176837 | 0.15 |
RP11-85B7.4 |
|
9730 |
0.26 |
chr1_54232654_54232848 | 0.15 |
ENSG00000201003 |
. |
4075 |
0.22 |
chr16_82687204_82687592 | 0.15 |
CDH13 |
cadherin 13 |
26700 |
0.24 |
chr7_98734981_98735368 | 0.15 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
6468 |
0.25 |
chr11_121966638_121966789 | 0.15 |
ENSG00000207971 |
. |
3839 |
0.19 |
chr6_85896028_85896266 | 0.15 |
NT5E |
5'-nucleotidase, ecto (CD73) |
263662 |
0.02 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.1 | 0.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 0.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.2 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.0 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:1904238 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.0 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.0 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.0 | 0.4 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) regulation of apoptotic process involved in morphogenesis(GO:1902337) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) regulation of apoptotic process involved in development(GO:1904748) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.0 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.3 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.6 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0010664 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.0 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.0 | 0.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.0 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.0 | 0.1 | GO:0009208 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) |
0.0 | 0.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.1 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.0 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.0 | GO:1903670 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0048242 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0060426 | lung vasculature development(GO:0060426) |
0.0 | 0.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.0 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0055026 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.1 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:0072172 | ureteric bud formation(GO:0060676) mesonephric tubule formation(GO:0072172) |
0.0 | 0.1 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.0 | 0.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.3 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.0 | 0.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.7 | GO:0030427 | site of polarized growth(GO:0030427) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.3 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 1.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0031545 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.0 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.0 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.0 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |